Skip to main content
OpenTrials
Completed

NCT Number: NCT04514874

Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020

The aeronautical community was also affected and greatly impacted economically and socially by the Covid-19 pandemic. Away from the acute phase, the epidemiological impact and the consequences of this disease within the French aviation flight crew population must be assessed. This study is aimed at providing original epidemiological data among civil and military aircrew, prior to possible prevention strategies or countermeasures to optimize risk management in terms of aviation safety and to promote, if necessary, future targeted studies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Percy, Clamart, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age
  • Professional military aircrew
  • Presenting himself/herself for a periodic medical exam

Exclusion criteria

  • Under 18 years of age
  • Parachutists
  • Non-professional aircrew
  • Presenting himself/herself for a first medical exam
  • Pregnant woman, parturient, breastfeeding

Treatment and study plan

Questionnaire

Other

Self-questionnaire about socio-demographical status, health status and lifestyle habits during and following the COVID-19 pandemic.

Primary outcomes

  1. Prevalence of COVID-19 infection among French military professional aircrew

    Time frame: At enrollment

    Prevalence of COVID-19 infection will be estimated on the basis of the replies to the questionnaire

Secondary outcomes

  1. Predictive factors of COVID-19 infection

    Time frame: At enrollment

    Predictive factors of COVID-19 infection will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.

  2. Techniques used for COVID-19 screening

    Time frame: At enrollment

    Techniques used for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)

  3. Reasons for COVID-19 screening

    Time frame: At enrollment

    Reasons for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)

  4. Experienced symptoms of COVID-19

    Time frame: At enrollment

    Experienced symptoms of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)

  5. Medical care of COVID-19

    Time frame: At enrollment

    Medical care of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)

  6. Social consequences of the COVID-19 pandemic

    Time frame: At enrollment

    Social consequences of the COVID-19 pandemic will be estimated on the basis of the replies to the questionnaire

  7. Factors associated with pejorative consequences of the COVID-19 pandemic

    Time frame: At enrollment

    Factors associated with pejorative consequences of the COVID-19 pandemic will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.

Sponsors and collaborators

Lead sponsor

Direction Centrale du Service de Santé des Armées

Other

Registry information

Acronym: Covaé

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Aug 17, 2020
Registry last updated
May 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.